College Park, MD, United States of America

Tinoush Moulaei


 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tinoush Moulaei: Innovator in Viral Inhibition

Introduction

Tinoush Moulaei is a notable inventor based in College Park, MD (US). He has made significant contributions to the field of viral inhibition through his innovative research and inventions. With a total of 4 patents, Moulaei has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Moulaei has developed modified griffithsin polypeptides. These inventions comprise the amino acid sequence of SEQ ID NO: 1, along with corresponding nucleic acids, vectors, cells, fusion proteins, constructs, conjugates, and methods aimed at inhibiting viral infection. His work in this area is crucial for advancing therapeutic strategies against viral diseases.

Career Highlights

Moulaei has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Louisville Research Foundation, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field.

Collaborations

Some of his notable coworkers include Barry R O'Keefe and Kenneth E Palmer. Their collaborative efforts have contributed to the success of his research and inventions.

Conclusion

Tinoush Moulaei's innovative work in the field of viral inhibition showcases his dedication to advancing medical science. His patents and collaborations reflect his significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…